Edges in Network
| Network | GSE5851_egf1520 - GSE5851 - SiGN-BN HC+Bootstrap |
| Network Description | Phase II exploratory pharmacogenomics study of cetuximab monotherapy in patients with advanced metastatic CRC |
| Node | MT1P2 |
| Upstream (Parents) |
|---|
| (<<) HSD11B1 → MT1P2 |
| (<<) HSD17B2 → MT1P2 |
| (<<) NNMT → MT1P2 |
| (<<) ORM1 → MT1P2 |
| (<<) SAA4 → MT1P2 |
| Downstream (Children) |
|---|
| MT1P2 → AQP3 (>>) |
| MT1P2 → CBFA2T3 (>>) |
| MT1P2 → CBS (>>) |
| MT1P2 → CDR2 (>>) |
| MT1P2 → CTSF (>>) |
| MT1P2 → CXCL2 (>>) |
| MT1P2 → CYP4F2 (>>) |
| MT1P2 → DAZAP2 (>>) |
| MT1P2 → G0S2 (>>) |
| MT1P2 → GPX3 (>>) |
| MT1P2 → GYS1 (>>) |
| MT1P2 → HYAL1 (>>) |
| MT1P2 → IL18 (>>) |
| MT1P2 → MT1F (>>) |
| MT1P2 → MT1G (>>) |
| MT1P2 → PNPLA3 (>>) |
| MT1P2 → RAB5B (>>) |
| MT1P2 → RBKS (>>) |
| MT1P2 → RORA (>>) |
| MT1P2 → SHC2 (>>) |
| MT1P2 → ST3GAL1 (>>) |
| MT1P2 → ST3GAL6 (>>) |
| MT1P2 → TFPI2 (>>) |
